相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Hai-Yan Chen et al.
GUT (2019)
The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection
Elizabeth C. Townsend et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
New treatment options for delta virus: Is a cure in sight?
Cihan Yurdaydin
JOURNAL OF VIRAL HEPATITIS (2019)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
Ohad Etzion et al.
JOURNAL OF HEPATOLOGY (2019)
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2019)
Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016
Eshan U. Patel et al.
CLINICAL INFECTIOUS DISEASES (2019)
Hepatitis D Virus-Specific CD8D+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection
Helenie Kefalakes et al.
GASTROENTEROLOGY (2019)
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2019)
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
Anika Wranke et al.
LIVER INTERNATIONAL (2018)
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
Antonio Aguilera et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
Cihan Yurdaydin et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study
M. Bazinet et al.
JOURNAL OF HEPATOLOGY (2018)
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2018)
Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma
Giacomo Diaz et al.
MOLECULAR CANCER RESEARCH (2018)
Hepatitis D diagnostics:Utilization and testing in the United States
Parham Safaie et al.
VIRUS RESEARCH (2018)
Noninvasive markers for staging fibrosis in chronic delta hepatitis
V. Takyar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
Non-invasive fibrosis score for hepatitis delta
Gunnar L. Lutterkort et al.
LIVER INTERNATIONAL (2017)
Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain
Carlos Ordieres et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis - end of study results from the LOWR HDV-3 study
C. Koh et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 study
C. Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Joanne M. Donkers et al.
SCIENTIFIC REPORTS (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
New treatments to reach functional cure: Virological approaches
David Durantel
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
Henry L. Y. Chan et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria
Oluyinka Oladele Opaleye et al.
VIROLOGY JOURNAL (2016)
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg plus Chronic Hepatitis B Infection
Mamun Al-Mahtab et al.
PLOS ONE (2016)
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Onur Keskin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia
Lamia Yocoubi et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Hepatitis delta virus testing, epidemiology and management: A multicentre cross-sectional study of patients in London
Kate El Bouzidi et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Hepatitis delta virus infection in Romania: prevalence and risk factors
Journal of Gastrointestinal and Liver Diseases (2015)
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2015)
Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
Tatyana Kushner et al.
JOURNAL OF HEPATOLOGY (2015)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Faseeha Noordeen et al.
PLOS ONE (2015)
Effects of HDV infection and pegylated interferon a treatment on the natural killer cell compartment in chronically infected individuals
Sebastian Lunemann et al.
GUT (2015)
Derivation of Phase 3 Dosing for Peginterferon Lambda-1a in Chronic Hepatitis C, Part 1: Modeling Optimal Treatment Duration and Sustained Virologic Response Rates
Xiaodong Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Long-term therapy of chronic delta hepatitis with peginterferon alfa
T. Heller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Characterization of Hepatitis Delta Virus in Sub-Saharan Africa
Iris E. Andernach et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Molecular epidemiology of hepatitis delta virus in the Western Pacific region
Meifang Han et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
B. Calle Serrano et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
Anika Wranke et al.
PLOS ONE (2014)
Nucleic Acid Polymers Prevent the Establishment of Duck Hepatitis B Virus Infection In Vivo
Faseeha Noordeen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Nucleic Acid Polymers Inhibit Duck Hepatitis B Virus Infection In Vitro
Faseeha Noordeen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Hepatitis B Virus Hepatotropism Is Mediated by Specific Receptor Recognition in the Liver and Not Restricted to Susceptible Hosts
Alexa Schieck et al.
HEPATOLOGY (2013)
Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California
Robert G. Gish et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
Emanuel K. Manesis et al.
JOURNAL OF HEPATOLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes
Harold Dickensheets et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Coinfection of hepatitis B and hepatitis delta virus in Belgium: A multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection
E. Ho et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
Marc Luetgehetmann et al.
HEPATOLOGY (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment
Jan Grabowski et al.
LIVER INTERNATIONAL (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection
Andrew J. Muir et al.
HEPATOLOGY (2010)
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine
Wael Mansour et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D
Melanie Schaper et al.
JOURNAL OF HEPATOLOGY (2010)
Outcome of chronic delta hepatitis in Italy: A long-term cohort study
Grazia Anna Niro et al.
JOURNAL OF HEPATOLOGY (2010)
Prevalence, Correlates, and Viral Dynamics of Hepatitis Delta among Injection Drug Users
Lauren M. Kucirka et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Phosphorylation of Serine 177 of the Small Hepatitis Delta Antigen Regulates Viral Antigenomic RNA Replication by Interacting with the Processive RNA Polymerase II
Shiao-Ya Hong et al.
JOURNAL OF VIROLOGY (2010)
Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction
Andreas Schulze et al.
JOURNAL OF VIROLOGY (2010)
Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities
Nicole E. Pagliaccetti et al.
VIROLOGY (2010)
Prevalence and Molecular Diversity of Hepatitis B Virus and Hepatitis Delta Virus in Urban and Rural Populations in Northern Gabon in Central Africa
Maria Makuwa et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Characterization of the nuclear localization signal of the hepatitis delta virus antigen
Carolina Alves et al.
VIROLOGY (2008)
Interleukin-22 but not interleukin-17 provides protection to Hepatocytes during acute liver inflammation
Lauren A. Zenewicz et al.
IMMUNITY (2007)
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues
Matthieu Blanchet et al.
JOURNAL OF VIROLOGY (2007)
High frequency of hepatocellular carcinoma in Mongolia; Association with mono-, or co-infection with hepatitis C, B, and delta viruses
Tsendsuren Oyunsuren et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Efficacy of peginterferon alpha-2b in chronic hepatitis delta:: Relevance of quantitative RT-PCR for follow-up
Corinne Castelnau et al.
HEPATOLOGY (2006)
Eighth major clade for hepatitis delta virus
Frederic Le Gal et al.
EMERGING INFECTIOUS DISEASES (2006)
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
Grazia Anna Niro et al.
HEPATOLOGY (2006)
Treatment of chronic hepatitis delta with pegylated interferon-α2b
Andreas Erhardt et al.
LIVER INTERNATIONAL (2006)
Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation
A Vaillant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia
B Tsatsralt-Od et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon
S Viana et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study
GA Niro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Lambda interferon inhibits hepatitis B and C virus replication
MD Robek et al.
JOURNAL OF VIROLOGY (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a Deltavirus genus of at least seven major clades
N Radjef et al.
JOURNAL OF VIROLOGY (2004)
The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis
JJ Mu et al.
VIROLOGY (2004)
Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication
YJ Li et al.
JOURNAL OF VIROLOGY (2004)
Long-term benefit of interferon a therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
P Farci et al.
GASTROENTEROLOGY (2004)
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
S Radaeva et al.
HEPATOLOGY (2004)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles
BB Bordier et al.
JOURNAL OF VIROLOGY (2002)
Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm
JP Tavanez et al.
RNA (2002)
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases
TB Macnaughton et al.
JOURNAL OF VIROLOGY (2002)
Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome
G Moraleda et al.
JOURNAL OF VIROLOGY (2001)
A novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly
CH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
RNA-dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases
LE Modahl et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
G Fattovich et al.
GUT (2000)
分享论文
